30 results on '"de Freitas, Caroline S."'
Search Results
2. Agathisflavone, a natural biflavonoid that inhibits SARS-CoV-2 replication by targeting its proteases
3. SARS-CoV-2 engages inflammasome and pyroptosis in human primary monocytes
4. Correction: SARS-CoV-2 engages inflammasome and pyroptosis in human primary monocytes
5. N-(2-(arylmethylimino)ethyl)-7-chloroquinolin-4-amine derivatives, synthesized by thermal and ultrasonic means, are endowed with anti-Zika virus activity
6. Severe influenza infection is associated with inflammatory programmed cell death in infected macrophages
7. Macrophages undergo necroptosis during severe influenza A infection and contribute to virus-associated cytokine storm
8. VIP plasma levels associate with survival in severe COVID-19 patients, correlating with protective effects in SARS-CoV-2-infected cells
9. Simvastatin Downregulates the SARS-CoV-2-Induced Inflammatory Response and Impairs Viral Infection Through Disruption of Lipid Rafts
10. In vitro antiviral activity of the anti-HCV drugs daclatasvir and sofosbuvir against SARS-CoV-2, the aetiological agent of COVID-19
11. Lipid droplets fuel SARS-CoV-2 replication and production of inflammatory mediators
12. Atazanavir, Alone or in Combination with Ritonavir, Inhibits SARS-CoV-2 Replication and Proinflammatory Cytokine Production
13. SARS-CoV-2 induces inflammasome-dependent pyroptosis and downmodulation of HLA-DR in human monocytes, which can be prevented by atazanavir
14. Lipid droplets fuel SARS-CoV-2 replication and production of inflammatory mediators
15. VIP plasma levels associate with survival in severe COVID-19 patients, correlating with protective effects in SARS-CoV-2-infected cells
16. The in vitro antiviral activity of the anti-hepatitis C virus (HCV) drugs daclatasvir and sofosbuvir against SARS-CoV-2
17. Atazanavir inhibits SARS-CoV-2 replication and pro-inflammatory cytokine production
18. Neuraminidase from Influenza A and B Viruses is Susceptible to the Compound 4-(4-Phenyl-1H-1,2,3-Triazol-1-yl)-2,2,6,6-Tetramethylpiperidine-1- Oxyl
19. Agathisflavone, a Biflavonoid from Anacardium occidentale L., Inhibits Influenza Virus Neuraminidase
20. 2,8-bis(trifluoromethyl)quinoline analogs show improved anti-Zika virus activity, compared to mefloquine
21. Corrigendum: The clinically approved antiviral drug sofosbuvir inhibits Zika virus replication
22. Beyond Members of the Flaviviridae Family, Sofosbuvir Also Inhibits Chikungunya Virus Replication
23. Yellow fever virus is susceptible to sofosbuvir both in vitro and in vivo
24. Beyond members of the Flaviviridae family, sofosbuvir also inhibits chikungunya virus replication
25. Correction: Corrigendum: The clinically approved antiviral drug sofosbuvir inhibits Zika virus replication
26. The clinically approved antiviral drug sofosbuvir inhibits Zika virus replication
27. The clinically approved antiviral drug sofosbuvir impairs brazilian zika virus replication
28. Correction: Aureonitol, a Fungi-Derived Tetrahydrofuran, Inhibits Influenza Replication by Targeting Its Surface Glycoprotein Hemagglutinin
29. Aureonitol, a Fungi-Derived Tetrahydrofuran, Inhibits Influenza Replication by Targeting Its Surface Glycoprotein Hemagglutinin
30. Beyond Members of the FlaviviridaeFamily, Sofosbuvir Also Inhibits Chikungunya Virus Replication
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.